Aya Kuchiba

Featured in: Favicon

nature.com Favicon

aacrjournals.org Favicon

onlinelibrary.wiley.com Favicon

ard.bmj.com Favicon

cebp.aacrjournals.org

Articles

Short-term effectiveness and safety of rituximab versus cyclophosphamide for life-threatening ANCA-associated vasculitis: a propensity score analysis of the real-world nationwide database

Sep 19, 2023 | ard.bmj.com | Yuichi Ishikawa |Kei Tokutsu |Shingo Nakayamada |Aya Kuchiba

AbstractObjectives Life-threatening antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) with rapidly progressive glomerulonephritis (RPGN) and/or alveolar haemorrhage (AH) has a poor prognosis. Rituximab (RTX) is as effective as cyclophosphamide (CY) in remission induction therapy; however, the effectiveness and safety of RTX have not been established in life-threatening AAV.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →